Skip to main content

Advertisement

Log in

Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006

  • Published:
Maternal and Child Health Journal Aims and scope Submit manuscript

Abstract

Objective To identify factors associated with maternal hepatitis C virus (HCV) seroprevalence and transmission of HCV as identified by qualitative HCV ribonucleic acid (RNA) in the infants of human immunodeficiency virus (HIV) infected women delivering in New York State (NYS) in 2006. Study Design In this retrospective cohort study of HIV-exposed infants born in NYS, leftover infant plasma from HIV diagnostic testing was de-identified and tested for HCV. If HCV antibodies were detected, a second specimen collected when the infant was >2 months old was tested for HCV qualitative RNA. Multivariate logistic regression was used to identify factors associated with HCV seropositivity. Results In a final sample of 553 live birth events with perinatal HIV exposure, 21 (3.8 %) of tested infant specimens had HCV antibodies indicative of maternal HCV seropositivity. Maternal age at delivery of >35 years, Hispanic ethnicity, white race and injection drug use (IDU) were significantly associated with HCV seropositivity in multivariate analysis. No cases of HCV vertical transmission were identified among HCV exposed infant specimens. Conclusions This statewide population-based study of HIV-infected childbearing women shows HCV seroprevalence of 3.8 %. Maternal age of >35 years and IDU are the strongest predictors of HCV seropositivity. Although no viral transmission was documented, more comprehensive longitudinal testing would be required to conclude that HCV transmission did not occur.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

HCV:

Hepatitis C virus

HIV:

Human immunodeficiency virus

IDU:

Injection drug use

NHANES:

National Health and Nutrition Examination Survey

NYS:

New York State

NYSDOH:

New York State Department of Health

RNA:

Ribonucleic acid

References

  1. Denniston, M. M., et al. (2014). Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003–2010. Annals of Internal Medicine, 160(5), 293–300.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Hellard, M., Sacks-Davis, R., & Gold, J. (2009). Hepatitis C treatment for injection drug users: A review of the available evidence. Clinical Infectious Diseases, 49(4), 561–573.

    Article  PubMed  Google Scholar 

  3. Grebely, J., & G.J. Dore, G. J. (2011). What is killing people with hepatitis C virus infection? In Seminars in Liver Diseases.

  4. Trooskin, S. B., et al. (2015). Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program. Journal of General Internal Medicine, 30(7), 950–957.

    Article  PubMed  Google Scholar 

  5. Alter, M. J., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341(8), 556–562.

    Article  CAS  PubMed  Google Scholar 

  6. Arshad, M., El-Kamary, S., & Jhaveri, R. (2011). Hepatitis C virus infection during pregnancy and the newborn period–are they opportunities for treatment? Journal of Viral Hepatitis, 18(4), 229–236.

    Article  CAS  PubMed  Google Scholar 

  7. Yeung, L. T., King, S. M., & Roberts, E. A. (2001). Mother-to-infant transmission of hepatitis C virus. Hepatology, 34(2), 223–229.

    Article  CAS  PubMed  Google Scholar 

  8. Dunkelberg, J., et al. (2014). Hepatitis B and C in pregnancy: A review and recommendations for care. Journal of Perinatology, 34, 882–891.

    Article  CAS  PubMed  Google Scholar 

  9. Roberts, E. A., & Yeung, L. (2002). Maternal-infant transmission of hepatitis C virus infection. Hepatology, 36(5B), s106–s113.

    Article  PubMed  Google Scholar 

  10. Thaler, M., et al. (1991). Vertical transmission of hepatitis C virus. The Lancet, 338(8758), 17–18.

    Article  CAS  Google Scholar 

  11. Zanetti, A. R., et al. (1995). Mother-to-infant transmission of hepatitis C virus. Lombardy study group on vertical HCV transmission. Lancet, 345(8945), 289–291.

    Article  CAS  PubMed  Google Scholar 

  12. Birkhead, G. S., et al. (2010). Progress in prevention of mother-to-child transmission of HIV in New York State: 1988–2008. Journal of Public Health Management and Practice, 16(6), 481–491.

    Article  PubMed  Google Scholar 

  13. CDC. (2013). Testing for HCV infection: An update of guidance for clinicians and laboratorians. Morbidity and Mortality Weekly Report, 62(18), 362.

    Google Scholar 

  14. Heinze, G., & Schemper, M. (2002). A solution to the problem of separation in logistic regression. Statistics in Medicine, 21(16), 2409–2419.

    Article  PubMed  Google Scholar 

  15. Frederick, T., et al. (2009). Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: The Women’s Interagency HIV Study (WIHS). AIDS patient care and STDs, 23(11), 915–923.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Hagan, H., Thiede, H., & Des, D. C. (2005). Jarlais, HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS, 19, S199–S207.

    Article  PubMed  Google Scholar 

  17. AASLD/IDSA HCV Guidance Panel. (2015). Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology, 62(3), 932–954.

    Article  Google Scholar 

  18. Alter, M. J., et al. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. Morbidity and Mortality Weekly Report, 47(1), 1–39.

    Google Scholar 

  19. Smith, B. D., et al. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recommendations and Reports, 61(RR-4), 1–32.

    PubMed  Google Scholar 

  20. Santiago-Munoz, P., et al. (2005). Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. American Journal of Obstetrics and Gynecology, 193(3 Pt 2), 1270–1273.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Ghazaryan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghazaryan, L., Smith, L., Parker, M. et al. Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006. Matern Child Health J 20, 550–555 (2016). https://doi.org/10.1007/s10995-015-1853-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10995-015-1853-4

Keywords

Navigation